LDOS - Leidos Holdings Inc Stock Analysis
Leidos Holdings Inc (LDOS) is a publicly traded company listed on the NYSE. It operates in the Information Technology Services industry, part of the broader Technology sector. The company has a market capitalization of 24.60B, generates annual revenue of 17.33B, and reports net income of 1.41B. As of the latest data, the stock is trading at 192.42 USD.
From a valuation and risk perspective, the stock presents the following profile: The stock appears reasonably valued, potentially indicating balanced risk and return. The PEG ratio is above 2, which could imply the stock is overvalued based on its growth outlook. The company uses a significant amount of debt to finance its operations, which can boost returns but adds financial risk. The dividend yield (0.84%) is modest, often associated with growth-oriented companies. This stock tends to be less volatile than the overall market, often preferred by conservative investors.
Analyst recommendation stands at Buy (4.0), indicating current market sentiment. Institutional ownership is reported at 78.12%, reflecting confidence from large investors. Over the last 12 months, the stock has shown a performance of 17.24%, trading within a 52-week range of 123.62 - 205.77.
LDOS - Leidos Holdings Inc
192.42
Analyst Consensus
Buy 4.0
LDOS – Analyst Rating Summary
- Strong Buy: 8
- Buy: 7
- Hold: 8
- Sell: 0
- Strong Sell: 0
- Total Analysts: 23
| Index: | S&P 500 | P/E: | 17.95 | EPS (ttm): | 10.72 | Insider Own: | 0.74% | Shs Outstand: | 127.85M | Perf Week: | 1.08% |
| Market Cap: | 24.60B | Forward P/E: | 15.66 | EPS next Y: | 12.29 | Insider Trans: | -3.92% | Shs Float: | 126.91M | Perf Month: | -3.57% |
| Income(ttm): | 1.41B | PEG: | 2.30 | EPS next Q: | 2.58 | Inst Own: | 78.12% | Short Float: | 1.89% | Perf Quarter: | 7.50% |
| Revenue(ttm): | 17.33B | P/S: | 1.42 | EPS this Y: | 15.47% | Inst Trans: | -0.55% | Short Ratio: | 2.94 | Perf Half Y: | 32.37% |
| Book/sh: | 38.40 | P/B: | 5.01 | EPS next Y: | 4.22% | ROA: | 10.45% | Short Interest: | 2.39M | Perf Year: | 17.24% |
| Cash/sh: | 8.58 | P/C: | 22.43 | EPS next 5Y: | 7.81% | ROE: | 29.51% | 52W Range: | 123.62 - 205.77 | Perf YTD: | 33.57% |
| Dividend Est.: | 1.62 (0.84%) | P/FCF: | 17.75 | EPS past 3/5Y: | 20.53% 14.92% | ROIC: | 13.88% | 52W High: | 205.77 -6.49% | Beta: | 0.59 |
| Dividend TTM: | 1.60 (0.83%) | Quick Ratio: | 1.50 | Sales past 3/5Y: | 6.65% 8.47% | Gross Margin: | 17.61% | 52W Low: | 123.62 55.65% | Perf 5Y: | 88.13% |
| Dividend Ex-Date: | Dec 15, 2025 | Current Ratio: | 1.62 | EPS Y/Y TTM: | 22.17% | Oper. Margin: | 11.78% | RSI (14): | 54.44 | Volatility: | 1.94% 2.28% |
| Employees: | 48000 | Debt/Eq: | 1.07 | Sales Y/Y TTM: | 6.48% | Profit Margin: | 8.11% | Recom: | 1.88 | Target Price: | 219.08 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 1.06 | EPS Q/Q: | 5.48% | Payout: | 16.70% | Rel Volume: | 0.96 | Prev Close: | 188.44 |
| Sales Surprise: | 4.49% | EPS Surprise: | 12.35% | Sales Q/Q: | 6.66% | Earnings: | Nov 04 BMO | Avg Volume: | 814.60K | Price: | 192.42 |
| SMA20: | 0.80% | SMA50: | 0.94% | SMA200: | 17.20% | Undervalued: 13.86% | Volume: | 782,722 | Change: | 2.11% | |
Graham Classic formula value: 232.18
(P/E=8 * 1g) Min value: 152.19
(current P/E * 2g) Max value: 323.15
Average value: 235.84
About Leidos Holdings Inc
Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.